Evidence map›Paper›PMID 40308407›Full record

ReviewCureus2025

New Paradigms in Nephrology Nursing.

Andrea Pinto

Abstract readReview
In one paragraph

Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Andrea PintoNursing, Hospital Dr. Nélio Mendonça, Serviço de Saúde da Região Autónoma da Madeira (SESARAM) Entidade Pública Empresarial Regional Autónoma da Madeira (EPERAM), Funchal, PRT.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the aging of the population and better healthcare, more elderly and frail patients are reaching the terminal stage of chronic kidney disease (CKD). In Portugal, one of the European leaders in the incidence of renal function replacement therapy, hemodialysis and peritoneal dialysis continue to be the focus of treatment, even in patients with multiple comorbidities, low functional reserve, and care dependency. However, several studies have revealed that these therapies in fragile patients do not provide quality of life or a greater survival rate but are associated with increased suffering due to the loss of functional capacity, with a subsequent need to abandon dialysis. Nephrology nursing in Portugal has always followed this more technical aspect necessary for dialysis. However, it has not dedicated itself to conservative treatment or other nephrology areas requiring differentiated palliative care, such as cardiorenal syndrome (CRS). Conservative treatment is a valid alternative that corresponds to the continuation of comprehensive therapy for patients with CKD without resorting to dialysis techniques. It seeks to prevent the deterioration of residual renal function while alleviating symptoms and complications resulting from disease progression, with personalized palliative care support aimed at optimizing the physical, emotional, and spiritual well-being of the patient and their family. On the other hand, despite being palliative, patients with CRS can benefit from more invasive techniques such as assisted peritoneal ultrafiltration to control symptoms, along with an educational approach that promotes their empowerment. This need for a paradigm shift led us to implement a specific nursing consultation for conservative treatment and CRS, ensuring personalized monitoring of these illnesses. Palliative care must be an integral part of healthcare, not only for incurable and terminal diseases but also for chronic, advanced, and evolving conditions.

Indexed as

cardio-renal syndromechronic kidney disease (ckd)conservative kidney managementfrail patientsnursing care

Identifiers

PMID40308407
PMCPMC12042060

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.